Melatonin-MT1 signal is essential for endometrial decidualization

Area of Science:

• Reproductive Biology
• Endocrinology
• Cellular Biology

Background:

• Deficient decidualization of endometrial stromal cells (ESCs) is linked to adverse pregnancy outcomes.
• Melatonin is a hormone crucial for reproductive processes, and its receptor MT1 is implicated in pregnancy complications.
• The specific role of the melatonin-MT1 signaling pathway in decidualization is not well understood.

Purpose of the Study:

• To investigate the role of the melatonin-MT1 signaling pathway in human endometrial decidualization.
• To explore the potential of melatonin as a therapeutic agent for decidualization defects.

Main Methods:

• Analysis of MT1 expression in decidual stromal cells from miscarriages.
• In vitro induction of decidualization with MT1 knockdown and overexpression.
• Investigation of melatonin's effects on decidualization in normal and LPS-induced inflammation models.
• In vivo and in vitro experiments to assess LPS-induced decidualization resistance and melatonin's reversal effects.

Main Results:

• Decidual stromal cells from miscarriages showed reduced decidualization and lower MT1 expression.
• MT1 expression increased during in vitro decidualization induction; MT1 knockdown impaired decidualization, while overexpression promoted it.
• Melatonin enhanced decidualization and counteracted MT1 knockdown-induced deficiency.
• Lipopolysaccharide (LPS) induced inflammation and decidualization resistance by downregulating MT1, effects reversed by melatonin.

Conclusions:

• The melatonin-MT1 signaling pathway is crucial for endometrial decidualization.
• Melatonin plays a protective role against inflammation-induced decidualization resistance.
• Targeting the melatonin-MT1 pathway may offer a novel therapeutic strategy for pregnancy complications associated with deficient decidualization.